Cargando…
GCN5 HAT inhibition reduces human Burkitt lymphoma cell survival through reduction of MYC target gene expression and impeding BCR signaling pathways
GCN5, the catalytic subunit in the acetyltransferase modules of SAGA and ATAC, functions as a coactivator of gene transcription. The SAGA complex is recruited to chromatin by transcription factors such as MYC and E2F1 to facilitate acetylation of histones, especially H3 at lysine 9 (H3K9). Burkitt l...
Autores principales: | Farria, Aimee T., Mustachio, Lisa Maria, Akdemir, Zeynep H. Coban, Dent, Sharon Y.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791378/ https://www.ncbi.nlm.nih.gov/pubmed/31645904 http://dx.doi.org/10.18632/oncotarget.27226 |
Ejemplares similares
-
JNK/AP1 Pathway Regulates MYC Expression and BCR Signaling through Ig Enhancers in Burkitt Lymphoma Cells
por: Ding, Xiaoling, et al.
Publicado: (2020) -
GCN5 Regulates FGF Signaling and Activates Selective MYC Target Genes during Early Embryoid Body Differentiation
por: Wang, Li, et al.
Publicado: (2017) -
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015) -
KATs in Cancer: Functions and Therapies
por: Farria, Aimee, et al.
Publicado: (2015) -
Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
por: Seitz, Volkhard, et al.
Publicado: (2011)